Closing soon

A--NIMHD Randomized Controlled Trial

Description: The National Institute on Minority Health and Health Disparities intends to award a sole-source contract to Kaiser Foundation Research Institute to evaluate a clinical decision-support tool that provides individualized exercise recommendations for breast cancer survivors. The planned work includes feasibility and acceptability testing with about 10 clinicians and 30 survivors, followed by a randomized trial involving about 64 clinicians and 624 survivors, with intervention and usual-care groups. This active presolicitation seeks capability statements rather than competitive proposals, with responses due November 25, 2026.

Buyer
Released
Nov 10, 2026
Closes
Nov 25, 2026(8 days left)
See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
See your top 10 accounts